Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Patton John Stuart
Relationship:   Chief Scientific Offic...
City:   San Diego,
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   493,756    

Indirect Shares

   233,444      
Direct Value   $8,314,078    

Indirect Value

   $10,047,695      
Total Shares   727,200      
Total Value   $18,361,773      


Halozyme Therapeutics Inc $7,761,649 Nektar Therapeutics $552,429 Halozyme Therapeutics Inc $7,761,649 Nektar Therapeutics $552,429
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Halozyme Therapeutics Inc HALO Director 2014-08-19 179,876 2005-01-18 232,830    Premium*  
            Nektar Therapeutics NKTR Chief Scientific Offic... 2008-11-14 313,880 2006-05-15 614    Premium*  
* Premium Members only  

Records found :    63         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-01-13 4 AS $18.18 $363,733 I/I (20,000) 547,308 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-02-10 4 AS $20.00 $400,000 I/I (20,000) 527,308 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-03-01 4 A $0.01 $250 D/D 25,000 25,000 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-03-04 4 AS $22.00 $443,522 I/I (20,000) 507,308 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-12-15 4 S $19.42 $66,033 I/I (3,400) 2,211 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-12-16 4 GD $0.00 $0 I/I 4,030 503,278 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-01-14 4 OE $18.61 $588,076 I/I 31,600 534,878 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-03-14 4 A $0.00 $0 I/I 4,166 539,044 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-03-14 4 S $14.37 $21,368 I/I (1,487) 534,878 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-05-10 4 S $14.47 $25,323 I/I (1,750) 1,621 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-13 4 AS $20.00 $400,716 I/I (20,000) 513,657 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-18 4 OE $19.32 $669,341 I/I 34,645 548,302 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-19 4 OE $19.37 $452,386 I/I 23,355 571,657 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-27 4 AS $22.00 $440,000 I/I (20,000) 551,657 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2006-03-03 4 A $0.01 $103 I/I 10,333 561,990 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2006-03-07 4 S $19.80 $76,390 I/I (3,859) 558,131 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2006-05-04 4 A $2.80 $42,000 D/D 15,000 98,051 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2006-05-15 4 S $20.21 $33,003 I/I (1,633) 614 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2007-01-05 4 OE $14.52 $14,520 D/D 1,000 1,000 0 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2007-01-26 4 OE $13.29 $186,060 D/D 14,000 15,000 0 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2007-03-09 4 A $0.01 $150 D/D 15,001 328,542 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-14 4 AS $8.00 $131,397 D/D (16,400) 346,071 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-15 4 AS $8.00 $68,800 D/D (8,600) 337,471 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-21 4 AS $8.50 $214,870 D/D (25,000) 312,471 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-28 4 AS $8.30 $209,979 D/D (25,000) 6,247 0 -
  63  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us